BI Asset Management Fondsmaeglerselskab’s Biogen BIIB Stock Holding History

BI Asset Management Fondsmaeglerselskab’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.26M	Buy	10,446 +2,560	+32%	+$490K	0.02%	391
2026 Q1	$1.45M	Buy	7,886 +2,315	+42%	+$427K	0.02%	434
2025 Q4	$980K	Sell	5,571 -117	-2%	-$19.1K	0.01%	518
2025 Q3	$797K	Sell	5,688 -938	-14%	-$127K	0.01%	552
2025 Q2	$832K	Buy	6,626 +1,341	+25%	+$167K	0.01%	519
2025 Q1	$723K	Sell	5,285 -1,329	-20%	-$190K	0.01%	503
2024 Q4	$1.01M	Sell	6,614 -557	-8%	-$93.9K	0.01%	513
2024 Q3	$1.39M	Buy	7,171 +1,277	+22%	+$267K	0.02%	331
2024 Q2	$1.37M	Buy	5,894 +385	+7%	+$83.7K	0.02%	346
2024 Q1	$1.19M	Sell	5,509 -254	-4%	-$59.5K	0.02%	331
2023 Q4	$1.49M	Sell	5,763 -764	-12%	-$188K	0.03%	344
2023 Q3	$1.68M	Sell	6,527 -1,210	-16%	-$324K	0.04%	276
2023 Q2	$2.2M	Buy	7,737 +1,658	+27%	+$494K	0.05%	243
2023 Q1	$1.69M	Buy	6,079 +2,179	+56%	+$603K	0.04%	256
2022 Q4	$1.08M	Buy	3,900 +2,745	+238%	+$775K	0.03%	308
2022 Q3	$308K	Buy	1,155 +760	+192%	+$161K	0.02%	354
2022 Q2	$81K	Buy	+395	New	+$80.7K	﹤0.01%	451
2022 Q1	–	Sell	-2,271	Closed	-$545K	–	463
2021 Q4	$545K	Hold	2,271	–	–	0.02%	320
2021 Q3	$643K	Sell	2,271 -862	-28%	-$283K	0.02%	306
2021 Q2	$1.08M	Hold	3,133	–	–	0.04%	269
2021 Q1	$876K	Sell	3,133 -17,790	-85%	-$4.8M	0.04%	265
2020 Q4	$5.12M	Sell	20,923 -25,317	-55%	-$6.53M	0.22%	95
2020 Q3	$13.1M	Buy	46,240 +6,461	+16%	+$1.8M	0.6%	41
2020 Q2	$10.6M	Buy	39,779 +22,511	+130%	+$6.77M	0.55%	42
2020 Q1	$5.46M	Buy	17,268 +1,936	+13%	+$588K	0.32%	56
2019 Q4	$4.55M	Sell	15,332 -9,938	-39%	-$2.76M	0.22%	92
2019 Q3	$5.88M	Buy	25,270 +20,870	+474%	+$4.86M	0.29%	65
2019 Q2	$1.03M	Buy	+4,400	New	+$1.02M	0.05%	85

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab's BIIB Position: Q2 2026 in Review

BI Asset Management Fondsmaeglerselskab increased its Biogen (BIIB) stake by 32% in Q2 2026, buying an estimated $490K and bringing the position to 10,446 shares worth $2.26M. The position accounts for 0.02% of the portfolio, ranked #391.

BI Asset Management Fondsmaeglerselskab first reported a position in BIIB in Q2 2019 and has held it in 28 quarters since. The position peaked at $13.1M in Q3 2020. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

BI Asset Management Fondsmaeglerselskab held 10,446 shares of Biogen worth $2.26M as of Q2 2026.
BI Asset Management Fondsmaeglerselskab bought 2,560 Biogen shares in Q2 2026, an estimated $490K.
Biogen made up 0.02% of BI Asset Management Fondsmaeglerselskab's portfolio in Q2 2026, its #391 holding.
BI Asset Management Fondsmaeglerselskab first reported a position in Biogen in Q2 2019 and has held it in 28 quarters since.
BI Asset Management Fondsmaeglerselskab's Biogen position peaked at $13.1M in Q3 2020.
1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2026, filed 10 Aug 2026.